BBVA USA’s QuidelOrtho QDEL Stock Holding History

BBVA USA’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$51K	Buy	358 +313	+696%	+$42.1K	﹤0.01%	654
2021 Q2	$6K	Buy	+45	New	+$5.3K	﹤0.01%	904

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BBVA USA's QDEL Position: Q3 2021 in Review

BBVA USA increased its QuidelOrtho (QDEL) stake by 696% in Q3 2021, buying an estimated $42.1K and bringing the position to 358 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

BBVA USA first reported a position in QDEL in Q2 2021 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold QDEL as of Q3 2021.

BBVA USA held 358 shares of QuidelOrtho worth $51K as of Q3 2021.
BBVA USA bought 313 QuidelOrtho shares in Q3 2021, an estimated $42.1K.
QuidelOrtho made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #654 holding.
BBVA USA first reported a position in QuidelOrtho in Q2 2021 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.